ADA 2023 Insights


 

ADA 2023 Insights: The Effect of Tirzepatide Versus Insulin Degludec on Post Meal Glucose Control in Patients with Type 2 Diabetes (SURPASS-3 CGM)

2,757 views
August 30, 2023
Comments 3
Login to view comments. Click here to Login